{"url":"https://lda.senate.gov/api/v1/filings/bedecd07-ec3d-4ef4-9eb4-b466efb64082/","filing_uuid":"bedecd07-ec3d-4ef4-9eb4-b466efb64082","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/bedecd07-ec3d-4ef4-9eb4-b466efb64082/print/","filing_document_content_type":"text/html","income":null,"expenses":"190000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Maude Champagne","dt_posted":"2026-04-20T21:46:07-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1201 South 4800 West","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Salt Lake City","registrant_state":"UT","registrant_zip":"84184","registrant":{"id":401108897,"url":"https://lda.senate.gov/api/v1/registrants/401108897/","house_registrant_id":56654,"name":"BIOMERIEUX","description":null,"address_1":"1201 South 4800 West","address_2":null,"address_3":null,"address_4":null,"city":"Salt Lake City","state":"UT","state_display":"Utah","zip":"84184","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MAUDE CHAMPAGNE","contact_telephone":"+1 202-997-7044","dt_updated":"2026-01-30T17:50:20.718514-05:00"},"client":{"id":61402,"url":"https://lda.senate.gov/api/v1/clients/61402/","client_id":61402,"name":"BIOMERIEUX","general_description":"Medical diagnostics","client_government_entity":null,"client_self_select":true,"state":"UT","state_display":"Utah","country":"US","country_display":"United States of America","ppb_state":"UT","ppb_state_display":"Utah","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2024-08-01"},"lobbying_activities":[{"general_issue_code":"TAR","general_issue_code_display":"Tariff (miscellaneous tariff bills)","description":"Discussions regarding tariff proposals","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147455,"prefix":null,"prefix_display":null,"first_name":"PAUL","nickname":null,"middle_name":null,"last_name":"HARTMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147454,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"RICHTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Discussions regarding Veterans Affairs Appropriations Discussions regarding Indian Health Services Appropriations","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147454,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"RICHTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147455,"prefix":null,"prefix_display":null,"first_name":"PAUL","nickname":null,"middle_name":null,"last_name":"HARTMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues regarding womens health Equitable Community Access to Pharmacists Services Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147454,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"RICHTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147455,"prefix":null,"prefix_display":null,"first_name":"PAUL","nickname":null,"middle_name":null,"last_name":"HARTMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Discussions regarding PASTEUR Act, the RESULTS Act, CLIA Modernization, and antimicrobial resistance.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147455,"prefix":null,"prefix_display":null,"first_name":"PAUL","nickname":null,"middle_name":null,"last_name":"HARTMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147454,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"RICHTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}